290 related articles for article (PubMed ID: 10231454)
1. Bone histology in patients with nephrotic syndrome and normal renal function.
Mittal SK; Dash SC; Tiwari SC; Agarwal SK; Saxena S; Fishbane S
Kidney Int; 1999 May; 55(5):1912-9. PubMed ID: 10231454
[TBL] [Abstract][Full Text] [Related]
2. Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function.
Korkor A; Schwartz J; Bergfeld M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
J Clin Endocrinol Metab; 1983 Mar; 56(3):496-500. PubMed ID: 6822651
[TBL] [Abstract][Full Text] [Related]
3. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
Malluche HH; Goldstein DA; Massry SG
J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
[TBL] [Abstract][Full Text] [Related]
4. Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.
Freundlich M; Jofe M; Goodman WG; Salusky IB
Pediatr Nephrol; 2004 Apr; 19(4):400-7. PubMed ID: 14991389
[TBL] [Abstract][Full Text] [Related]
5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
7. Phosphorus control in peritoneal dialysis patients.
Yavuz A; Ersoy FF; Passadakis PS; Tam P; Evaggelos DM; Katopodis KP; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis GJ; Dombros NA; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis CP; Yavuz M; Tsakiris DJ; Dimitriades AC; Yilmaz ME; Gültekin M; Süleymanlar G; Oreopoulos DG
Kidney Int Suppl; 2008 Apr; (108):S152-8. PubMed ID: 18379539
[TBL] [Abstract][Full Text] [Related]
8. Sequential changes of biochemical bone parameters after kidney transplantation.
Reinhardt W; Bartelworth H; Jockenhövel F; Schmidt-Gayk H; Witzke O; Wagner K; Heemann UW; Reinwein D; Philipp T; Mann K
Nephrol Dial Transplant; 1998 Feb; 13(2):436-42. PubMed ID: 9509459
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
Portale AA; Booth BE; Halloran BP; Morris RC
J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
[TBL] [Abstract][Full Text] [Related]
10. Bone histology and calcium metabolism in patients with nephrotic syndrome and normal or reduced renal function.
Tessitore N; Bonucci E; D'Angelo A; Lund B; Corgnati A; Lund B; Valvo E; Lupo A; Loschiavo C; Fabris A
Nephron; 1984; 37(3):153-9. PubMed ID: 6738766
[TBL] [Abstract][Full Text] [Related]
11. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
[TBL] [Abstract][Full Text] [Related]
12. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings.
Demiaux B; Arlot ME; Chapuy MC; Meunier PJ; Delmas PD
J Clin Endocrinol Metab; 1992 May; 74(5):1146-51. PubMed ID: 1569162
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.
Findling JW; Adams ND; Lemann J; Gray RW; Thomas CJ; Tyrrell JB
J Clin Endocrinol Metab; 1982 May; 54(5):1039-44. PubMed ID: 6977549
[TBL] [Abstract][Full Text] [Related]
14. Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: a correlative clinical-histomorphometric study.
Gazit D; Tieder M; Liberman UA; Passi-Even L; Bab IA
J Clin Endocrinol Metab; 1991 Jan; 72(1):229-35. PubMed ID: 1986023
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
[TBL] [Abstract][Full Text] [Related]
16. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia.
Orwoll ES; Meier DE
J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418
[TBL] [Abstract][Full Text] [Related]
17. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
[TBL] [Abstract][Full Text] [Related]
18. Bone disease in patients with long-term renal transplantation and normal renal function.
Carlini RG; Rojas E; Weisinger JR; Lopez M; Martinis R; Arminio A; Bellorin-Font E
Am J Kidney Dis; 2000 Jul; 36(1):160-6. PubMed ID: 10873886
[TBL] [Abstract][Full Text] [Related]
19. Role of change in vitamin D metabolism with age in calcium and phosphorus metabolism in normal human subjects.
Fujisawa Y; Kida K; Matsuda H
J Clin Endocrinol Metab; 1984 Oct; 59(4):719-26. PubMed ID: 6541227
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans.
Marcus R; Madvig P; Young G
J Clin Endocrinol Metab; 1984 Feb; 58(2):223-30. PubMed ID: 6319444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]